APA (7th ed.) Citation

MS, H., NJ, G., SJ, K., EL, S., DA, J., & JS, S. (2014). Induced and pre-existing anti-polyethylene glycol antibody in a trial of every 3-week dosing of pegloticase for refractory gout, including in organ transplant recipients. Arthritis research & therapy, 16(2), R63. https://doi.org/10.1186/ar4500

Chicago Style (17th ed.) Citation

MS, Hershfield, Ganson NJ, Kelly SJ, Scarlett EL, Jaggers DA, and Sundy JS. "Induced and Pre-existing Anti-polyethylene Glycol Antibody in a Trial of Every 3-week Dosing of Pegloticase for Refractory Gout, Including in Organ Transplant Recipients." Arthritis Research & Therapy 16, no. 2 (2014): R63. https://doi.org/10.1186/ar4500.

MLA (9th ed.) Citation

MS, Hershfield, et al. "Induced and Pre-existing Anti-polyethylene Glycol Antibody in a Trial of Every 3-week Dosing of Pegloticase for Refractory Gout, Including in Organ Transplant Recipients." Arthritis Research & Therapy, vol. 16, no. 2, 2014, p. R63, https://doi.org/10.1186/ar4500.